Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy
Daniel A. Vallera, Hua Chen, Andrew R. Sicheneder, Angela Panoskaltsis-Mortari, Elizabeth P. TarasVolume:
33
Year:
2009
Language:
english
Pages:
10
DOI:
10.1016/j.leukres.2009.02.006
File:
PDF, 1.34 MB
english, 2009